Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Unruptured Vertebrobasilar Dissecting Aneurysms
NCT04943783Unknown
- Sponsor
- Beijing Neurosurgical Institute
- Start
- Jul 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of atorvastatin (2 arms), sponsored by Beijing Neurosurgical Institute. Primary endpoint: Change of aneurysm wall inflammation as measured by HR-VW-MRI at 6 months. Status: unknown.
02
Drugs
atorvastatin
Beyond the preview
Go deeper on NCT04943783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04943783.